Tag: US generic products
Mayne Pharma to acquire a portfolio of US generic products from Teva and Allergen
ASX-listed specialty pharmaceutical company Mayne Pharma has entered into a binding agreement to acquire a portfolio of US generic products from Teva and Allergen for...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
